Results 31 to 40 of about 7,701 (203)

Investigation of the relationship between different Candida species and some risk factors affecting the incidence of Vulvovaginal Candidiasis [PDF]

open access: yesMajallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2019
Introduction: Vulvovaginal candidiasis (VVC) is a yeast infection and is one of the most common causes of women's referral to the physician. The aim of this study was to investigate the relationship between different Candida species and some risk factors
Seyedeh Sedigheh Hosseini   +11 more
doaj   +1 more source

Study of vulvovaginal candidiasis in symptomatic women of reproductive age group attending tertiary care institute, Haryana province

open access: yesAsian Journal of Medical Sciences, 2021
Background: Abnormal vaginal discharge results from a variety of infectious and noninfectious causes. Vulvovaginal candidiasis (VVC) is caused by the overgrowth of Candida species in the vagina and is characterized by itching, erythema and curd like ...
Gulnar K , Harman Multani
doaj   +1 more source

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern

open access: yesBMC Women's Health, 2018
Background Vulvovaginal candidiasis is a global issue of concern due to its association with economic costs, sexually transmitted infections, and ascending genital tract infection.
Adane Bitew, Yeshiwork Abebaw
doaj   +1 more source

Modern concepts of etiopathogenesis and approaches to the treatment of recurrent vulvovaginal candidiasis [PDF]

open access: yesVestnik Dermatologii i Venerologii, 2023
Vulvovaginal candidiasis is a widespread infection caused by Candida. The disease affects 7580% of women of reproductive age at least once during their lifetime, and 920% of them indicate the presence of three or more episodes of the disease during the ...
Margarita R. Rakhmatulina
doaj   +1 more source

β-Glucan induces reactive oxygen species production in human neutrophils to improve the killing of Candida albicans and Candida glabrata isolates from vulvovaginal candidiasis. [PDF]

open access: yesPLoS ONE, 2014
Vulvovaginal candidiasis (VVC) is among the most prevalent vaginal diseases. Candida albicans is still the most prevalent species associated with this pathology, however, the prevalence of other Candida species, such as C. glabrata, is increasing.
Patricia de Souza Bonfim-Mendonça   +9 more
doaj   +1 more source

Effect of Continuous Care Model on Recurrence of Vulvovaginal Candidiasis Infection among Pregnant Women [PDF]

open access: yesEgyptian Journal of Health Care
Background: Recurrent Vulvovaginal candidiasis infection is a global health problem for pregnant women associated with negative impacts on sexual and family lives that requires specific control practices.
Doaa Shehta Said   +3 more
doaj   +1 more source

Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot study. [PDF]

open access: yesPLoS ONE, 2018
OBJECTIVE:To characterize the lipid profile in vaginal discharge of women with vulvovaginal candidiasis, cytolytic vaginosis, or no vaginal infection or dysbiosis. DESIGN:Cross-sectional study.
José Marcos Sanches   +8 more
doaj   +1 more source

Generalidades de la candidiasis vulvovaginal

open access: yes, 2023
Vulvovaginal Candidiasis is a disease caused by Candida species, mainly Candida albicans, which can colonize the vaginal mycoflora of healthy women, without causing disease.
González Garro, Ángela   +2 more
core   +2 more sources

Comparison of Single Dose Sertaconazole versus Three Dose Clotrimazole Regime in Treatment of Uncomplicated Vulvovaginal Candidiasis- A Prospective Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2019
Introduction: Vulvovaginal candidiasis is the second most common vaginitis following bacterial vaginitis amongst the reproductive age group with variable compliance to the treatment.
Katha Desai, Pradip Sambarey
doaj   +1 more source

Antimicrobial photodynamic therapy in Candida spp. biofilms: In vitro and in vivo protocols

open access: yesPhotochemistry and Photobiology, EarlyView.
This review addresses the critical challenges in translating in vitro antimicrobial photodynamic therapy protocols to in vivo models, with a particular focus on the hurdles of standardization. The vast diversity in photosensitizers and light parameters across different target cells and models requires a rigorous optimization process.
Lívia Mara Alves Figueiredo‐Godoi   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy